Association of traditional Chinese medicine therapy and the risk of dementia in patients with hypertension: a nationwide population-based cohort study

BackgroundPatients with hypertension (HTN) reportedly have a higher risk of developing dementia. However, it remains unclear if use of Traditional Chinese Medicine (TCM), the most common form of complementary and alternative medicine, can help lower the risk of dementia for these patients. So the aim of the study was to investigate the effects of TCM on dementia risk among patients with hypertension.MethodsThis longitudinal cohort study used the Taiwanese National Health Insurance Research Database (NHIRD) to identify 143,382 newly diagnosed hypertension patients aged 20–90 years who received treatment between 1998 and 2007. Among them, 52,365 (36.52%) had received TCM after the onset of hypertension (TCM users), and the remaining 91,017 patients (63.48%) were designated as a control group (non-TCM users). All enrollees were followed until the end of 2012 to record the incidence of dementia. A Cox proportional hazards regression model was used to compute the hazard ratio (HR) of dementia in patients who received TCM.ResultsDuring the 15-year follow-up, 3933 TCM users and 10,316 non-TCM users developed dementia, representing an incidence rate of 8.41 and 11.55%, respectively, per 1000 person-years. TCM users had a significantly reduced risk of dementia compared to non-TCM users (adjusted HR = 0.76; 95% confidence interval [CI] = 0.74–0.81). The predominant effect was observed among those treated with TCM longer than 180 days (adjusted HR = 0.65; 95% CI = 0.62–0.69). Among the commonly used TCM products, Tian-Ma-Gou-Teng-Yin, Dan-Shen (Radix Salviae Miltiorrhizae), Chuan-Niu-Xi (Radix Cyathulae), Ge-Gen (Radix Puerariae), Jia-Wei-Xiao-Yao-San, and Jue-Ming-Zi (Semen Cassiae) were significantly associated with a lower risk of dementia.ConclusionsResults from this population-based study support the effects of TCM on reducing dementia risk, which may provide a reference for dementia prevention strategies.

[1]  Tom Fleischer,et al.  Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia , 2016, Medicine.

[2]  Stanley C. C. Chik,et al.  Pharmacological Effects of Active Compounds on Neurodegenerative Disease with Gastrodia and Uncaria Decoction, a Commonly Used Poststroke Decoction , 2013, TheScientificWorldJournal.

[3]  Jaung-Geng Lin,et al.  Gender Differences in Traditional Chinese Medicine Use among Adults in Taiwan , 2012, PloS one.

[4]  A. Sharrett,et al.  Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[6]  Hong Xie,et al.  Neuroprotective effect of the active components of three Chinese herbs on brain iron load in a mouse model of Alzheimer’s disease , 2015, Experimental and therapeutic medicine.

[7]  Q. Han,et al.  Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson’s disease , 2015, Scientific Reports.

[8]  Lenore J Launer,et al.  Midlife Pulse Pressure and Incidence of Dementia: The Honolulu-Asia Aging Study , 2006, Stroke.

[9]  P. Raina,et al.  Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline , 2008, Annals of Internal Medicine.

[10]  Wenhua Zheng,et al.  Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates β-amyloid deposition through upregulating α-secretase in vivo and in vitro , 2009, Neuroscience Letters.

[11]  Pau-Chung Chen,et al.  Population-Based Case–Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk , 2010, Journal of the National Cancer Institute.

[12]  Young-Chul Chung,et al.  Therapeutic potential of Gastrodia elata Blume for the treatment of Alzheimer's disease , 2013, Neural regeneration research.

[13]  K. Woo,et al.  The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. , 2009, Journal of alternative and complementary medicine.

[14]  M. Oh,et al.  Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  F. Tsai,et al.  Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility , 2015, PloS one.

[16]  Karen Bandeen-Roche,et al.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. , 2014, JAMA neurology.

[17]  C. DeCarli,et al.  Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline , 2011, Alzheimer's & Dementia.

[18]  H. Brodaty,et al.  ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.

[19]  Justin C. Y. Wu,et al.  Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. , 2014, Journal of Alzheimer's disease : JAD.

[20]  Lei Xu,et al.  In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid β-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors. , 2011, Environmental toxicology and pharmacology.

[21]  Hui Zhang,et al.  Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells. , 2009, Basic & clinical pharmacology & toxicology.

[22]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[23]  Shun-Ku Lin,et al.  Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study. , 2014, Journal of ethnopharmacology.

[24]  Shun-Ku Lin,et al.  The traditional Chinese medicine prescription patterns for migraine patients in Taiwan: a population-based study. , 2014, Journal of ethnopharmacology.

[25]  Jian He,et al.  Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode , 2015, BMC Complementary and Alternative Medicine.

[26]  Jose Viña,et al.  Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[27]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[28]  Kai Sun,et al.  Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage , 2015, Acta pharmaceutica Sinica. B.

[29]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[30]  Haiying Zhang,et al.  Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways , 2011, Experimental Gerontology.

[31]  S. Malaivijitnond,et al.  Neurotherapeutic Effects of Pueraria mirifica Extract in Early‐ and Late‐Stage Cognitive Impaired Rats , 2016, Phytotherapy research : PTR.

[32]  Akihiko Takashima,et al.  Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's β‐amyloid proteins , 2006, Journal of neuroscience research.

[33]  Jie Gu,et al.  Traditional Chinese Medicine for Senile Dementia , 2011, Evidence-based complementary and alternative medicine : eCAM.

[34]  K. Koike,et al.  Anxiolytic-like effect of Shigyakusan extract with low side effects in mice , 2013, Journal of Natural Medicines.

[35]  H. Chung,et al.  Chinese prescription Kangen-karyu and Salviae Miltiorrhizae Radix improve age-related oxidative stress and inflammatory response through the PI3K/Akt or MAPK pathways. , 2014, The American journal of Chinese medicine.

[36]  T. Ishikawa,et al.  Effectiveness of the Kampo kami‐shoyo‐san (TJ‐24) for tremor of antipsychotic‐induced parkinsonism , 2000, Psychiatry and clinical neurosciences.

[37]  Xianying Zeng,et al.  Characterization and antioxidant activities of the polysaccharides from Radix Cyathulae officinalis Kuan. , 2015, International journal of biological macromolecules.

[38]  Shun-Ku Lin,et al.  The traditional Chinese medicine prescription patterns of Sjögren׳s patients in Taiwan: a population-based study. , 2014, Journal of ethnopharmacology.

[39]  Dong Hyun Kim,et al.  Cassia obtusifolia seed ameliorates amyloid β-induced synaptic dysfunction through anti-inflammatory and Akt/GSK-3β pathways. , 2016, Journal of ethnopharmacology.

[40]  Donald T. Stuss,et al.  The Dementias , 1996, Brain and Cognition.

[41]  Jiping Qi,et al.  Inhibition of glycogen synthase kinase‐3β by Angelica sinensis extract decreases β‐amyloid‐induced neurotoxicity and tau phosphorylation in cultured cortical neurons , 2011, Journal of neuroscience research.

[42]  Sungha Park,et al.  A potential therapeutic effect of saikosaponin C as a novel dual‐target anti‐Alzheimer agent , 2016, Journal of neurochemistry.

[43]  References , 1971 .

[44]  R. Mayeux,et al.  Low-density lipoprotein cholesterol and the risk of dementia with stroke. , 1999, JAMA.

[45]  Sindy Hu,et al.  Characteristics of traditional Chinese medicine users and prescription analysis for pediatric atopic dermatitis: a population-based study , 2016, BMC Complementary and Alternative Medicine.

[46]  Kelvin Chan,et al.  Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. , 2011, Journal of ethnopharmacology.

[47]  X. Xiong,et al.  Effects of Traditional Chinese Patent Medicine on Essential Hypertension: A Systematic Review , 2015 .

[48]  R. Deyo,et al.  ADAPTING A CLINICAL COMORBIDITY USE WITH ICD-g-CM ADMINISTRATIVE INDEX FOR DATABASES , 1992 .

[49]  Mao-Feng Sun,et al.  Prescription patterns of Chinese herbal products for patients with fractures in Taiwan: A nationwide population-based study. , 2015, Journal of ethnopharmacology.

[50]  Ming-Chi Lu,et al.  Decreased risk of stroke in patients receiving traditional Chinese medicine for vertigo: A population-based cohort study. , 2016, Journal of ethnopharmacology.

[51]  Young Hoon Kim,et al.  Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: A 16‐week open trial , 2007, Psychiatry and clinical neurosciences.

[52]  A. Kibel.  Population-Based Case–Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk , 2010 .